JIR
BNTX icon

James Investment Research’s BioNTech BNTX Stock Holding History

James Investment Research’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-16
Closed -$2K – 312
2023
Q1 		$2K Hold
16
– – ﹤0.01% 540
2022
Q4 		$2K Hold
16
– – ﹤0.01% 530
2022
Q3 		$2K Hold
16
– – ﹤0.01% 497
2022
Q2 		$2K Sell
16
-141
-90% -$21.5K ﹤0.01% 484
2022
Q1 		$27K Buy
157
+12
+8% +$2.02K ﹤0.01% 397
2021
Q4 		$37K Sell
145
-21
-13% -$5.75K ﹤0.01% 400
2021
Q3 		$45K Sell
166
-1
-0.6% -$318 ﹤0.01% 382
2021
Q2 		$37K Buy
+167
New +$31.5K ﹤0.01% 405

Other funds holding BNTX

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
AGA
Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

James Investment Research's BNTX Position: Q2 2023 in Review

James Investment Research sold out of BioNTech (BNTX) in Q2 2023, closing a stake of 16 shares — an estimated $2K sold.

James Investment Research first reported a position in BNTX in Q2 2021 and held it in 8 quarters. The position peaked at $45K in Q3 2021. 253 funds tracked by Wall St. Rank hold BNTX as of Q2 2023.

  • James Investment Research reported no remaining BioNTech position as of Q2 2023 after selling out during the quarter.
  • James Investment Research sold 16 BioNTech shares in Q2 2023, an estimated $2K.
  • James Investment Research first reported a position in BioNTech in Q2 2021 and held it in 8 quarters.
  • James Investment Research's BioNTech position peaked at $45K in Q3 2021.
  • 253 funds tracked by Wall St. Rank held BioNTech as of Q2 2023.

Based on James Investment Research's 13F filing for Q2 2023, filed 7 Aug 2023.